Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-405498
Filing Date
2014-11-10
Accepted
2014-11-10 13:47:57
Documents
13
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d782731d10q.htm 10-Q 681181
2 EX-10.1 d782731dex101.htm EX-10.1 176803
3 EX-31.1 d782731dex311.htm EX-31.1 6127
4 EX-31.2 d782731dex312.htm EX-31.2 6102
5 EX-32.1 d782731dex321.htm EX-32.1 3041
6 EX-32.2 d782731dex322.htm EX-32.2 3002
13 GRAPHIC g782731logo.jpg GRAPHIC 4996
  Complete submission text file 0001193125-14-405498.txt   4119174

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT orex-20140930.xml EX-101.INS 495636
8 XBRL TAXONOMY EXTENSION SCHEMA orex-20140930.xsd EX-101.SCH 38081
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE orex-20140930_cal.xml EX-101.CAL 54822
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE orex-20140930_def.xml EX-101.DEF 215462
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE orex-20140930_lab.xml EX-101.LAB 286615
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE orex-20140930_pre.xml EX-101.PRE 253875
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Filer) CIK: 0001382911 (see all company filings)

EIN.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33415 | Film No.: 141207891
SIC: 2834 Pharmaceutical Preparations